CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

Social Responsibility

Fully Embracing Social Responsibility

Social topics such as access to medications for all patients are of key importance for the entire pharmaceutical industry. When it comes to the safety of medicines, the risks associated with CHEPLAPHARM’s business model are relatively low thanks to its good, long-standing track record. With products sold to patients in over 120 countries throughout the world, we help people with health conditions in a wide range of indications, including rare diseases.  

Our Commitment to our Employees 

As at 30 September 2021, CHEPLAPHARM employed 459 people from more than 24 countries – cultural diversity has long been a tradition with us and is something we are proud of. That is because recruiting, retaining and training new and existing talent whilst ensuring equal opportunities for all employees is something of fundamental importance to us at CHEPLAPHARM.

That is also why we are committed to promoting a family-friendly working environment. Going hand-in-hand with this are part-time working models and flexible working hours with a view to helping our employees balance their career and family life. With management training courses we also prepare our employees specifically for managerial positions. It thus comes as no surprise that we currently have a share of women of 57% compared with the average of other pharmaceutical companies in Germany of 41%. We also lead the way with the share of women in management positions of 46% versus the average of 29% over all sectors in Germany.

This is certainly not least owing to our efforts to promote and support talented and motivated employees. For instance, we have introduced a talent management system throughout the Company which includes targeted higher-qualification training measures, such as a training programme for executive staff development in collaboration with external coaches.

To continuously promote and enhance our corporate organisation of as a whole, it is essential for us to engage all our employees in a mutual exchange of perspectives over all management levels. This allows our employees to join a working group providing the Management with regular feedback and suggestions for improvements. A further tool enabling us to work together to grow the Company is our employee survey on the quality of management within teams. The results of this survey, which ran for the first time in 2020, were analysed and translated into specific actions to improve the quality of collaboration in our Company in relation to value-added activities.

In 2020, staff turnover declined to 11.4% after 15.6% in 2019. The share of part-time employment contracts also fell to 7.2% (2019: 8.5%).

Quality is Our Top Priority 

CHEPLAPHARM supplies pharmaceutical products to millions of patients around the world and fulfils this responsibility by providing safe and reliable products. For this reason, our company currently employs more than 60 people in its own quality assurance department who follow an established quality management system that includes thorough CAPA (Corrective and Preventive Action) management. CHEPLAPHARM strictly adheres to Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) for the pharmaceutical industry.

Social Responsibility in the Supply Chain 

Our 2021 supplier survey documents that: 

  • 79% of our suppliers operate a quality management system based on HACCP principles or according to ISO 9001 or equivalent standards; 
  • 93% offer regular training on employee and product safety in manufacturing environments; 
  • 86% have detailed policies on child labour and forced labour in place across their supply chain; and 
  • 93% of our suppliers have a complaints management system.

Discovering Investor Relations

More ESG topics

Back to top expand_less